Mechanisms of Renal Fibrosis (original) (raw)
Abstract
Tubulointerstitial fibrosis is a chronic and progressive process affecting kidneys during aging and in chronic kidney disease (CKD), regardless of cause. CKD and renal fibrosis affect half of adults above age 70 and 10% of the world's population. Although no targeted therapy yet exists to slow renal fibrosis, a number of important recent advances have clarified the cellular and molecular mechanisms underlying the disease. In this review, I highlight these advances with a focus on cells and pathways that may be amenable to therapeutic targeting. I discuss pathologic changes regulating interstitial myofibroblast activation, including profibrotic and proinflammatory paracrine signals secreted by epithelial cells after either acute or chronic injury. I conclude by highlighting novel therapeutic targets and approaches with particular promise for development of new treatments for patients with fibrotic kidney disease.
Article metrics loading...
/content/journals/10.1146/annurev-physiol-022516-034227
2018-02-10
2024-11-19
Full text loading...
/deliver/fulltext/physiol/80/1/annurev-physiol-022516-034227.html?itemId=/content/journals/10.1146/annurev-physiol-022516-034227&mimeType=html&fmt=ahah
- Article Type: Review Article
Most Read This Month
Article
content/journals/physiol
Journal
5
3
false
en